MedPath

The Association Between Overweight and Oocyte Diameter in Women Undergoing Vitro Fertilization

Conditions
Obesity
Infertility
Interventions
Other: Oocyte Measurement
Registration Number
NCT01672931
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

We believe that there is an association between BMI and oocyte diameter in women undergoing IVF treatments. We plan to measure the oocyte diameter in 2 groups of women undergoing IVF. One group will have BMI 20-25 and the other group will have BMI above 30.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • IVF treated patients
  • BMI between 20-25 or over 30
Exclusion Criteria
  • Everyone else

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
BMI 20-25Oocyte MeasurementWomen undergoing IVF treatments with BMI between 20-25
BMI over 30Oocyte MeasurementWomen undergoing IVF with BMI over 30
Primary Outcome Measures
NameTimeMethod
Larger Size of Oocyte DiameterOne year

Oocyte will be measured in women undergoing IVF treatment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

© Copyright 2025. All Rights Reserved by MedPath